Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

ECOG 1609 A Phase III Randomized Study of Adjuvant Ipilimumab Anti-CTLA4 Therapy


Collapse Overview 
Collapse sponsor award id
E1609


Collapse Biography 

Collapse Time 
Collapse start date
2011-10-25